Feed Preview

Genome Surgery & Neuronal Disorders

Genome Surgery & Neuronal Disorders diagram by Meletios Verras, Shutterstock
Meletios Verras, Shutterstock

Genome surgery using CRISPR genomic techniques offer the potential to correct disease-causing mutations in many neuronal disorders. Here are the latest discoveries pertaining to genome surgery and neuronal disorders.

Top 20 most recent papers
Cell Research

Meningeal lymphatic vessels regulate brain tumor drainage and immunity

Cell ResearchFebruary 26, 2020
Xueting HuJincai Luo
34
1
Lancet Neurology

Towards a treatment for genetic prion disease: trials and biomarkers

Lancet NeurologyMarch 22, 2020
Sonia M VallabhEric S Lander
14
Chemical Science

Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease

Chemical ScienceMarch 20, 2020
Anna HuefnerRoger A Barker
Journal of Hematology & Oncology

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer

Journal of Hematology & OncologyMarch 1, 2020
Lulu LiJinquan Cai
Frontiers in Veterinary Science

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

Frontiers in Veterinary ScienceMarch 29, 2020
Brett D StoryHeather L Gray-Edwards
International Journal of Molecular Sciences

Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy

International Journal of Molecular SciencesMarch 28, 2020
Maria CsobonyeiovaLubos Danisovic
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeuticsFebruary 20, 2020
Julia MarschallingerLudwig Aigner
3
1
Pharmacology & Therapeutics

Role of the ERO1-PDI interaction in oxidative protein folding and disease

Pharmacology & TherapeuticsMarch 24, 2020
Andrea G ShergalisNouri Neamati
1
Frontiers in Neuroscience

Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia

Frontiers in NeuroscienceMarch 11, 2020
Gabriella PaparellaAndrea Martinuzzi
International Journal of Molecular Sciences

Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies

International Journal of Molecular SciencesFebruary 14, 2020
Karolina PierzynowskaGrzegorz Węgrzyn
International Journal of Molecular Sciences

Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology

International Journal of Molecular SciencesMarch 19, 2020
Magdalena DabrowskaMarta Olejniczak

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

© 2020 Meta ULC. All rights reserved
/feed-previews/genome-surgery-neuronal-disorders/46af9a03-6bab-45f4-a4c4-2f46679f9852